Omniab Inc Stock Forecast, Predictions & Price Target

Analyst price target for OABI

Based on 3 analysts offering 12 month price targets for Omniab Inc.
Min Forecast
Avg Forecast
Max Forecast

Should I buy or sell OABI stock?

Based on 3 analysts offering ratings for Omniab Inc.
Strong Buy
Strong Buy
1 analysts 33.33%
2 analysts 66.67%
0 analysts 0%
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their OABI stock forecasts and price targets.

OABI stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Bottom 1%
Bottom 11%
Strong BuyReiterates$8.00+59.68%2023-05-12
Bottom 7%
BuyInitiates Coverage On$10.00+99.60%2023-04-13

1 of 1

OABI vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
OABI$5.01$9.67+92.95%Strong Buy
FDMT$13.91$28.25+103.09%Strong Buy
TVTX$7.85$21.10+168.79%Strong Buy

Omniab Stock Forecast FAQ

Is Omniab Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: OABI) stock is to Strong Buy OABI stock.

Out of 3 analysts, 1 (33.33%) are recommending OABI as a Strong Buy, 2 (66.67%) are recommending OABI as a Buy, 0 (0%) are recommending OABI as a Hold, 0 (0%) are recommending OABI as a Sell, and 0 (0%) are recommending OABI as a Strong Sell.

If you're new to stock investing, here's how to buy Omniab stock.

What is OABI's Price Target?

According to 3 Wall Street analysts that have issued a 1 year OABI price target, the average OABI price target is $9.67, with the highest OABI stock price forecast at $11.00 and the lowest OABI stock price forecast at $8.00.

On average, Wall Street analysts predict that Omniab's share price could reach $9.67 by Aug 11, 2024. The average Omniab stock price prediction forecasts a potential upside of 92.95% from the current OABI share price of $5.01.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.